SA Catana Group (ALCAT)
Euronext Paris · France · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 1.690 |
|---|---|
| 52-week range | 1.630 – 2.998 |
| Return, 1 month / 3 months | −7.2% / −8.5% |
| Return, 1 year / 3 years | −42.9% / −66.7% |
| Trend | Below its 200-day average |
| RSI (14) | 37 |
| Volatility (1 year) | 34.2% |
| Worst drawdown (1 year) | -44.0% |
| Average daily value traded | 0.06M EUR |
| Dividend yield | 7.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SA Catana Group designs and builds sailing catamarans, which it markets under its Catana and Bali brands. The Catana range is aimed at performance-oriented sailors, while the Bali line offers cruising catamarans with open living spaces and practical features for family and charter use. The company is based in Canet-en-Roussillon in southern France, and its boats are sold through a dealer network to private owners and charter operators in markets around the world.
On this site SA Catana Group appears as a stock on the Euronext Paris (France), code ALCAT, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SA Catana Group (ALCAT) trades on the Euronext Paris in France. It last closed at EUR 1.690 on 19 October 2026.
Its price-based Market X-Ray is 41 out of 100 (a weak price profile), ranking 420 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 42.9% and over the last three months it fell 8.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 22 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -23.8% | ||
| From 52-week high | -43.1% | ||
| Momentum | 29 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.5% | ||
| 6-month return | -26.2% | ||
| 12-month return, skipping the last month | -38.4% | ||
| Stability (higher is calmer) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -44.0% | ||
| Liquidity | 59 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.06M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 72 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 7.7% | ||
| Years with dividends | 5 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −7.9% |
|---|---|
| 1 month | −7.2% |
| 3 months | −8.5% |
| 6 months | −26.2% |
| 1 year | −42.9% |
| 3 years | −66.7% |
| 5 years | −67.8% |
Signals
| 50-day / 200-day average | 1.832 / 2.218 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.064 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Mar 2026 | EUR 0.1300 |
| 4 Mar 2025 | EUR 0.1800 |
| 5 Mar 2024 | EUR 0.1500 |
| 1 Mar 2023 | EUR 0.1500 |
| 2 Mar 2022 | EUR 0.1300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.